Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

By Tochikubo K.   Isaka M.   Yasuda Y.   Kozuka S.   Matano K.   Miura Y.   Taniguchi T.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 150-155

Elsevier

Access to resources Recommend Favorite

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine

By Carlsson R.-M.R.-M.   Claesson B.A.   Kayhty H.   Selstam U.   Iwarson S.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 468-478

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

By Baqar S.   Bourgeois A.L.   Schultheiss P.J.   Walker R.I.   Rollins D.M.   Haberberger R.L.   Pavlovskis O.R.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 22-28

Elsevier

Access to resources Recommend Favorite

Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)

By Matsuo K.   Yoshikawa T.   Asanuma H.   Iwasaki T.   Hagiwara Y.   Chen Z.   Kadowaki S.-e.   Tsujimoto H.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2713-2722

Elsevier

Access to resources Recommend Favorite

Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route

By Vines R.R.   Perdue S.S.   Moncrief J.S.   Sentz D.R.   Barroso L.A.   Wright R.L.   Wilkins T.D.  

Vaccine, Vol. 19, Iss. 6, 2000-11 ,pp. : 655-660

Elsevier

Access to resources Recommend Favorite